Downregulation of Lymphoid enhancer‐binding factor 1 (<i>LEF‐1)</i> expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologic features

<h3>Introduction</h3><p dir="ltr">Lymphoid enhancer-binding factor 1 (<i>LEF-1</i>) overexpression has been recently remarkably reported in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and has shown utility in distinguishing CLL/SLL from o...

Full description

Saved in:

Bibliographic Details
Main Author:	Dina S. Soliman (14779333) (author)
Other Authors:	Einas Al‐Kuwari (14779336) (author), Kodappully S Siveen (14779339) (author), Rajaa Al‐Abdulla (14779342) (author), Prem Chandra (9072038) (author), Mohamed Yassin (4166515) (author), Abdulqader Nashwan (14779345) (author), Feryal A Hilmi (14779348) (author), Ruba Y Taha (14779351) (author), Zafar Nawaz (96166) (author), Halima El‐Omri (14779354) (author), Jericha M Mateo (14779357) (author), Ahmad Al‐Sabbagh (14779360) (author)
Published:	2020
Subjects:	Biomedical and clinical sciences Cardiovascular medicine and haematology Oncology and carcinogenesis atypical CLL Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) Flow cytometry Immunohistochemistry ymphoid enhancer-binding factor 1 (LEF-1)
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Downregulation of Lymphoid enhancer‐binding factor 1 (<i>LEF‐1)</i> expression (by immunohistochemistry and/ flow cytometry) in chronic Lymphocytic Leukemia with atypical immunophenotypic and cytologic features

Similar Items